Dr. Reddy's Labs Launches Lamotrigine Orally Disintegrating Tablets In U.S.

(RTTNews) - Dr. Reddy's Laboratories Ltd. (500124, DRREDDY, RDY) said it has launched Lamotrigine Orally Disintegrating Tablets in 25 mg, 50 mg, 100 mg, and 200 mg, a therapeutic equivalent generic version of Lamictal ODT (lamotrigine) Orally Disintegrating Tablets in the United States market approved by the U.S. Food & Drug Administration.

The Lamictal ODT brand and generic had U.S. sales of about $65.5 million MAT for the most recent twelve months ending in July 2016, according to IMS Health. Lamictal ODT is a registered trademark of GSK group of companies.

Dr. Reddy's Lamotrigine Orally Disintegrating Tablets 25 mg, 50 mg, 100 mg, and 200 mg are available in bottle count sizes of 30s.